Pacira BioSciences Inc
PCRX
Market Cap$1.27B
Close$
$73.37
168.6% upside
Current Fair Value
168.6% upsideUndervalued by 168.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.27 Billion |
|---|---|
| Enterprise Value | $1.51 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.81 |
| Beta | 0.53 |
| Outstanding Shares | 46,523,185 |
| Avg 30 Day Volume | 438,777 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 30.29 |
|---|---|
| PEG | -8.75 |
| Price to Sales | 1.95 |
| Price to Book Ratio | 1.52 |
| Enterprise Value to Revenue | 2.24 |
| Enterprise Value to EBIT | 17.35 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
ESG Score
No data